Institutional Ownership
Nasus Pharma Ltd
CUSIP M7071P109ORD SHSNSRXQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
21.1%
Max % of class reported
Institutional Holders
9
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Nov 13, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Balyasny Asset Management L.P. | 898.5K | $1.99M |
| 2 | Cable Car Capital, LP | 602.0K | $1.34M |
| 3 | Velan Capital Investment Management LP | 359.4K | $797.8K |
| 4 | Hudson Bay Capital Management LP | 134.8K | $299.2K |
| 5 | Bleichroeder LP | 89.8K | $199.5K |
| 6 | Empery Asset Management, LP | 45.8K | $101.7K |
| 7 | Ubs Group AG | 3.1K | $6.9K |
| 8 | Morgan Stanley | 2.0K | $4.4K |
| 9 | Hrt Financial LP | 38.9K | $86 |